Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 836 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 476.91 USD | -2.22% | -5.56% | -9.93% | +12.58% | 11.02 B USD | ||
| 859 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.89 USD | -0.56% | -6.20% | -14.78% | +1.65% | 10.63 B USD | ||
| 865 |  IBRX ImmunityBio, Inc. - Common Stock | 9.91 USD | +1.64% | +5.20% | +25.92% | +302.85% | 10.50 B USD | ||
| 892 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.75 USD | +1.01% | +4.55% | +1.76% | +98.61% | 10.02 B USD | ||
| 909 |  KRYS Krystal Biotech, Inc. - Common Stock | 327.30 USD | +0.84% | +0.17% | -6.18% | +74.91% | 9.69 B USD | ||
| 910 |  PCVX Vaxcyte, Inc. - Common Stock | 65.02 USD | -2.90% | +14.49% | +8.38% | +53.71% | 9.68 B USD | ||
| 941 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 109.30 USD | +0.88% | -1.74% | -5.24% | +84.94% | 9.09 B USD | ||
| 943 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 139.91 USD | -0.72% | -0.77% | -4.20% | +86.22% | 9.05 B USD | ||
| 955 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 170.08 USD | -1.67% | -6.36% | -18.22% | +30.63% | 8.91 B USD | ||
| 971 |  CYTK Cytokinetics, Incorporated - Common Stock | 62.01 USD | +1.46% | -6.68% | -16.55% | +6.73% | 8.62 B USD | ||
| 973 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 60.74 USD | -1.20% | -6.05% | -28.25% | +55.35% | 8.58 B USD | ||
| 997 |  TGTX TG Therapeutics, Inc. - Common Stock | 53.34 USD | +0.74% | -1.53% | -1.88% | +53.01% | 8.16 B USD | ||
| 1049 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 263.55 USD | -5.20% | -9.16% | -22.39% | +380.40% | 7.36 B USD | ||
| 1058 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 43.30 USD | -1.95% | -1.97% | -23.04% | -39.96% | 7.20 B USD | ||
| 1068 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 79.90 USD | -1.18% | -12.35% | -9.28% | +234.17% | 7.05 B USD | ||
| 1075 |  ABVX Abivax SA - American Depositary Shares | 89.05 USD | +2.34% | -7.07% | -24.41% | -4.76% | 6.99 B USD | ||
| 1145 |  IMVT Immunovant, Inc. - Common Stock | 30.26 USD | -5.56% | -11.26% | -22.63% | +57.52% | 6.25 B USD | ||
| 1151 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 89.64 USD | +1.35% | -5.61% | -10.63% | -18.74% | 6.17 B USD | ||
| 1167 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 13.31 USD | +3.02% | -7.95% | +59.98% | +507.76% | 6.03 B USD | ||
| 1172 |  BLTE Belite Bio Inc - American Depositary Shares | 152.52 USD | -2.28% | -6.72% | -15.39% | +94.37% | 6.00 B USD |
Notizie Biotechnology Stocks
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
AbCellera presenterà dati di fase 1/2 sul farmaco per la menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |